# The utilization and challenges of Japan's MID‐NET<sup>®</sup> medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-utilization-and-challenges-of-japan-s-mid-net-sup-sup-medical-information/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kaori Yamada,Maori Itoh,Yoshiaki Fujimura,Michio Kimura,Koichiro Murata,Naoki Nakashima,Masaharu Nakayama,Kazuhiko Ohe,Takao Orii,Eizaburo Sueoka,T. Suzuki,Hideto Yokoi,Chieko Ishiguro,Yoshiaki Uyama,on behalf of MID‐NET project group |
| Citations | 40 |
| DOI | 10.1002/pds.4777 |
| Fields | Medicine,Pharmacology, Toxicology and Pharmaceutics |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2932605241 |
| PMID | 30945387 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Takao Orii](https://scholariq.org/researchers/takao-orii/)

## Paper primary topic

- [Pharmacovigilance and Adverse Drug Reactions](https://scholariq.org/topics/pharmacovigilance-and-adverse-drug-reactions/)

## Paper topics

- [Pharmacovigilance and Adverse Drug Reactions](https://scholariq.org/topics/pharmacovigilance-and-adverse-drug-reactions/)
- [Pharmaceutical Practices and Patient Outcomes](https://scholariq.org/topics/pharmaceutical-practices-and-patient-outcomes/)
- [Pharmacy and Medical Practices](https://scholariq.org/topics/pharmacy-and-medical-practices/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.